Limited Stage Small Cell Lung Cancer Clinical Trials in Indianapolis, Indiana
2 recruitingIndianapolis, Indiana
Showing 1–2 of 2 trials
Recruiting
Phase 2
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
SCLCSmall Cell Lung CancerLimited Stage Small Cell Lung Cancer+1 more
Hirva Mamdani84 enrolled4 locationsNCT05903092
Recruiting
Phase 2
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC250 enrolled33 locationsNCT06773910